Vima Therapeutics, Inc.
4 known investors
Vima Therapeutics is a biotechnology company developing a novel oral therapy for people living with movement disorders such as dystonia and Parkinson's disease, aiming to help patients regain control of movement by targeting the underlying biology of disease. It focuses on neurological conditions affecting patients in the United States.
BiotechHealthtechMedical Devices
Investors · 4
Frequently asked questions
- What does Vima Therapeutics, Inc. do?
- Vima Therapeutics is a biotechnology company developing a novel oral therapy for people living with movement disorders such as dystonia and Parkinson's disease, aiming to help patients regain control of movement by targeting the underlying biology of disease. It focuses on neurological conditions affecting patients in the United States.
- Who are Vima Therapeutics, Inc.'s investors?
- Vima Therapeutics, Inc.'s investors include Access Biotechnology, Atlas Venture, Canaan Partners, Frazier Life Sciences.